glp-1 agonist treatment information sources agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis GLP-1 agonists approved for clinical
Description
Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies
Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes
COA included
Ozempic alternatives for weight loss span branded medications, compounded formulations, and lifestyle-based approaches
